Cargando…
Inappropriate costimulation and aberrant DNA methylation as therapeutic targets in angioimmunoblastic T-cell lymphoma
Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common subtypes of peripheral T-cell lymphoma. Advances in understanding the mutational landscape of AITL have not resulted in improved prognosis nor consensus regarding optimal first-line and second-line treatment. The recently proposed m...
Autores principales: | Willemsen, Mathijs, Schouten, Harry C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299773/ https://www.ncbi.nlm.nih.gov/pubmed/28194275 http://dx.doi.org/10.1186/s40364-017-0085-8 |
Ejemplares similares
-
Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways
por: Willemsen, Mathijs, et al.
Publicado: (2018) -
Targeting TET2 as a Therapeutic Approach for Angioimmunoblastic T Cell Lymphoma
por: Hu, Lina, et al.
Publicado: (2022) -
New battlefields for costimulation
por: Martin-Orozco, Natalia, et al.
Publicado: (2006) -
A Rare Case of Angioimmunoblastic T-Cell Lymphoma with Epstein-Barr Virus-Negative Reed-Sternberg-Like B-Cells, Chylous Ascites, and Chylothorax
por: Willemsen, Mathijs, et al.
Publicado: (2017) -
CUTANEOUS INVOLVEMENT IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
por: Papadavid, Evangelia, et al.
Publicado: (2010)